During the past decade, Velocity Clinical Research, Austin conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 2 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 2 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Velocity Clinical Research, Austin" #1 sponsor was "Pfizer" with 2 trials, followed by "Bond Avillion 2 Development LP" with 1 trials sponsored, "Eli Lilly and Company" with 1 trials sponsored, "Emergent BioSolutions" with 1 trials sponsored and "FluGen Inc" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Velocity Clinical Research, Austin" #1 collaborator was "Parexel" with 1 trials as a collaborator and "United States Department of Defense" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Velocity Clinical Research, Austin" are "Asthma" (1 trials), "Chikungunya Virus" (1 trials), "Chikungunya Virus Infection" (1 trials), "Cytomegalovirus Infection" (1 trials) and "Episodic Migraine" (1 trials). Many other conditions were trialed in "Velocity Clinical Research, Austin" in a lesser frequency.

Most popular intervention types in "Velocity Clinical Research, Austin" are "Biological" (6 trials), "Drug" (4 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "AS MDI" (1 trials), "BDA MDI" (1 trials), "CHIKV VLP/adjuvant" (1 trials) and "Cam2020 M2SR H3N2 influenza vaccine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Velocity Clinical Research, Austin" are 9 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Velocity Clinical Research, Austin". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Velocity Clinical Research, Austin, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Velocity Clinical Research, Austin, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".